Close Menu

NEW YORK – Luminex reported on Sunday an 11 percent year-over-year increase in its preliminary fourth quarter revenues.

For Q4 2019, the Austin, Texas-based company recorded $90.4 million in revenues compared to $81.1 million in revenues in the year-ago period. The revenue figure misses the consensus Wall Street estimate of $91.2 million.

Luminex said it anticipates it will be profitable for Q4 2019.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

UK Royal Statistical Society is organizing a working group to develop guidelines for assessing COVID-19 tests, the Guardian reports.

The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.

President Donald Trump's "good genes" comment raises eugenics concerns, CNN reports.

In PLOS this week: genetic analysis of tremor condition, analysis of a West and Central African tree used in traditional medicine, and more.